Solaris Asset Management LLC increased its position in Aetna Inc. (NYSE:AET) by 0.8% during the second quarter, Holdings Channel reports. The firm owned 32,281 shares of the company’s stock after buying an additional 255 shares during the period. Aetna accounts for 3.0% of Solaris Asset Management LLC’s portfolio, making the stock its 3rd largest position. Solaris Asset Management LLC’s holdings in Aetna were worth $4,901,000 at the end of the most recent quarter.
A number of other institutional investors also recently modified their holdings of the company. FTB Advisors Inc. boosted its position in shares of Aetna by 11.0% in the first quarter. FTB Advisors Inc. now owns 977 shares of the company’s stock worth $125,000 after buying an additional 97 shares during the period. Signature Estate & Investment Advisors LLC bought a new position in shares of Aetna during the first quarter worth about $133,000. Liberty Capital Management Inc. boosted its position in shares of Aetna by 206.9% in the second quarter. Liberty Capital Management Inc. now owns 933 shares of the company’s stock worth $144,000 after buying an additional 629 shares during the period. Horan Capital Management bought a new position in shares of Aetna during the first quarter worth about $157,000. Finally, Guardian Life Insurance Co. of America boosted its position in shares of Aetna by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 1,353 shares of the company’s stock worth $173,000 after buying an additional 9 shares during the period. Hedge funds and other institutional investors own 91.73% of the company’s stock.
Shares of Aetna Inc. (NYSE AET) opened at 152.42 on Friday. The company has a market capitalization of $50.62 billion, a P/E ratio of 33.83 and a beta of 0.54. The stock’s 50 day moving average price is $154.28 and its 200-day moving average price is $138.79. Aetna Inc. has a 52-week low of $104.59 and a 52-week high of $161.69.
Aetna (NYSE:AET) last posted its quarterly earnings data on Thursday, August 3rd. The company reported $3.42 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.34 by $1.08. The company had revenue of $15.52 billion during the quarter, compared to analyst estimates of $15.34 billion. Aetna had a return on equity of 20.52% and a net margin of 2.52%. The firm’s quarterly revenue was down 2.7% on a year-over-year basis. During the same quarter last year, the company earned $2.21 earnings per share. On average, equities analysts expect that Aetna Inc. will post $9.46 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which was paid on Friday, July 28th. Investors of record on Thursday, July 13th were paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 1.31%. The ex-dividend date of this dividend was Tuesday, July 11th. Aetna’s dividend payout ratio is 43.67%.
ILLEGAL ACTIVITY NOTICE: “Aetna Inc. (NYSE:AET) Stake Increased by Solaris Asset Management LLC” was originally published by Ticker Report and is the sole property of of Ticker Report. If you are reading this news story on another publication, it was stolen and reposted in violation of international trademark and copyright legislation. The correct version of this news story can be read at https://www.tickerreport.com/banking-finance/2802797/aetna-inc-nyseaet-stake-increased-by-solaris-asset-management-llc.html.
Several equities analysts have recently weighed in on the company. Deutsche Bank AG lifted their price objective on Aetna from $144.00 to $157.00 and gave the company a “hold” rating in a report on Thursday, July 13th. Jefferies Group LLC reiterated a “hold” rating and set a $133.00 price objective on shares of Aetna in a report on Thursday, April 13th. Credit Suisse Group reiterated a “buy” rating and set a $155.00 price objective on shares of Aetna in a report on Wednesday, May 17th. Cowen and Company set a $170.00 price objective on Aetna and gave the company a “buy” rating in a report on Saturday, May 27th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and set a $175.00 price objective (up previously from $150.00) on shares of Aetna in a report on Wednesday. Eight research analysts have rated the stock with a hold rating and seventeen have given a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $157.09.
In related news, EVP Margaret M. Mccarthy sold 27,028 shares of Aetna stock in a transaction on Wednesday, June 7th. The stock was sold at an average price of $149.23, for a total transaction of $4,033,388.44. Following the completion of the sale, the executive vice president now owns 33,563 shares of the company’s stock, valued at $5,008,606.49. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Chairman Mark T. Bertolini sold 103,547 shares of Aetna stock in a transaction on Wednesday, May 17th. The shares were sold at an average price of $140.79, for a total value of $14,578,382.13. Following the sale, the chairman now directly owns 659,888 shares of the company’s stock, valued at approximately $92,905,631.52. The disclosure for this sale can be found here. 0.90% of the stock is currently owned by company insiders.
Aetna Company Profile
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc. (NYSE:AET).
Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.